Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FYCKA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,437
Award facts
- Contract value 100% obligated
- $26,436.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a ceiling value of $26,436.87. This firm fixed-price delivery order, which is expected to be completed by September 12, 2025, carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this order under its existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
Dupixent is a specialty biologic medication used to treat conditions such as atopic dermatitis, asthma, and eosinophilic conditions, making it a critical pharmaceutical for military healthcare systems and veteran care. The delivery order reflects AmerisourceBergen Drug Corp's established role as a primary pharmaceutical vendor for the Defense Logistics Agency, supporting the military health system's requirement for specialty medications and medical supplies. As a non-set-aside competitive award, this order demonstrates the contractor's continued capability to meet federal procurement standards for specialized pharmaceutical products across the military healthcare enterprise.
Quick answers
Who was awarded contract SPE2DB25FYCKA?
SPE2DB25FYCKA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FYCKA worth?
The government has obligated $26,437 on SPE2DB25FYCKA.
Is contract SPE2DB25FYCKA an order under another contract?
Yes. SPE2DB25FYCKA is a delivery order under SPE2DB20D3505, an indefinite delivery contract.
Was contract SPE2DB25FYCKA competed?
The extent of competition for SPE2DB25FYCKA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award